Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Haemonetics's EPS for the twelve months ending Sep 26, 2026 was $2.24, down 34.5% year over year. For fiscal 2026 it was $2.05, down 38.1% from the year before. The highest annual figure on record is $3.31 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $2.05 | -38.1% |
| FY2025 | Mar 29, 2025 | $3.31 | +44.5% |
| FY2024 | Mar 30, 2024 | $2.29 | +2.2% |
| FY2023 | Apr 1, 2023 | $2.24 | +166.7% |
| FY2022 | Apr 2, 2022 | $0.84 | -45.8% |
| FY2021 | Apr 3, 2021 | $1.55 | +4.7% |
| FY2020 | Mar 28, 2020 | $1.48 | +42.3% |
| FY2019 | Mar 30, 2019 | $1.04 | +22.4% |
| FY2018 | Mar 31, 2018 | $0.85 | – |
| FY2017 | Apr 1, 2017 | -$0.51 | – |
| FY2016 | Apr 2, 2016 | -$1.09 | -440.6% |
| FY2015 | Mar 28, 2015 | $0.32 | -52.2% |
| FY2014 | Mar 29, 2014 | $0.67 | -9.5% |
| FY2013 | Mar 30, 2013 | $0.74 | -43.1% |
| FY2012 | Mar 31, 2012 | $1.30 | -16.7% |
| FY2011 | Apr 2, 2011 | $1.56 | +39.3% |
| FY2010 | Apr 3, 2010 | $1.12 | -1.3% |
| FY2009 | Mar 28, 2009 | $1.14 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | $1.00 | +23.5% |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $0.72 | +2.9% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | -$0.43 | -136.8% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $0.95 | +28.4% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $0.81 | +22.7% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $0.70 | -5.4% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $1.17 | +192.5% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $0.74 | +21.3% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $0.66 | +37.5% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $0.74 | -7.5% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $0.40 | -29.8% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $0.61 | -4.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $0.48 | -25.0% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $0.80 | +110.5% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $0.57 | +200.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $0.64 | +42.2% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $0.64 | +120.7% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $0.38 | – |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $0.19 | – |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $0.45 | -27.4% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $0.29 | -69.1% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | -$0.09 | -142.9% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | -$0.22 | -164.7% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $0.62 | +6.9% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $0.94 | +30.6% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $0.21 | – |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $0.34 | -15.0% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $0.58 | +65.7% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $0.72 | +105.7% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | -$0.17 | – |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $0.40 | +81.8% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $0.35 | – |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $0.35 | -7.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$0.05 | -113.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $0.22 | – |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | -$0.12 | -140.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $0.38 | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $0.38 | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | -$0.98 | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $0.30 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?